Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026)
Alcon (ALC) posted Non-Current Deferred Tax Liability of $841.0 million for Q2 2026, down 10.91% on a QoQ basis from $944.0 million in Q1 2026, and down 1.87% year-over-year from $857.0 million in Q2 2025.
Analysis
Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Alcon has reported Non-Current Deferred Tax Liability for 11 years, with the latest figure at $841.0 million in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 1.87% year-over-year to $841.0 million in Q2 2026; TTM through Jun 2026 was $841.0 million, a 1.87% decrease from a year earlier, with the FY2025 full-year figure at $941.0 million, up 29.97% from the prior year.
- Non-Current Deferred Tax Liability was $841.0 million for Q2 2026 at Alcon, down from $944.0 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $2.0 billion in Q4 2022, with the low at -$212.0 million in Q1 2025.
- Average Non-Current Deferred Tax Liability over 5 years is $900.0 million, with a median of $903.5 million recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Non-Current Deferred Tax Liability slumped 125.92% in 2025, then jumped 545.28% in 2026.
- Over 5 years, Non-Current Deferred Tax Liability stood at $2.0 billion in 2022, then slumped by 59.99% to $797.0 million in 2023, then declined by 9.16% to $724.0 million in 2024, then advanced by 29.97% to $941.0 million in 2025, then dropped by 10.63% to $841.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $841.0 million (Q2 2026), $944.0 million (Q1 2026), and $941.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 841.00 Mn |
| Mar 31, 2026 | 944.00 Mn |
| Dec 31, 2025 | 941.00 Mn |
| Sep 30, 2025 | 911.00 Mn |
| Jun 30, 2025 | 857.00 Mn |
| Mar 24, 2025 | -212.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Sep 30, 2024 | 785.00 Mn |
| Jun 30, 2024 | 792.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Dec 31, 2023 | 797.00 Mn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.10 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.99 Bn |
| Sep 30, 2022 | 918.00 Mn |
| Jun 30, 2022 | 896.00 Mn |
| Mar 31, 2022 | 951.00 Mn |
| Dec 31, 2021 | 1.78 Bn |
| Sep 30, 2021 | 1.07 Bn |